Search research articles
Contact Us
Filters
Showing results (191-200 of 245) with videos related to
Page
of 25
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1985
Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysis
B L Powell, D V Jackson, C W Scarantino, et al.
Cancer
|
April 15, 1981
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trial
H B Muss, V Howard, F Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B
A B Kornblith, D R Hollis, E Zuckerman, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: toxicity and response
C J Bowden, W D Figg, N A Dawson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1986
Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association
F Richards, L D Case, D R White, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1996
Clinical and experimental evidence of inhibition of testosterone production by suramin
R Danesi, R V La Rocca, M R Cooper, et al.
Cancer
|
February 1, 1975
Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma
J H Moon, S Gailani, M R Cooper, et al.
Cancer Treatment Reports
|
July 1, 1985
Phase I study of high-dose cytarabine and cisplatin in patients with advanced malignancy
J N Atkins, H B Muss, R L Capizzi, et al.
The New England Journal of Medicine
|
May 5, 1994
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma
W C Wood, D R Budman, A H Korzun, et al.
Cancer
|
May 1, 1981
Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of Bacillus Calmette-Guerin (MER) in advanced breast cancer: a randomized trial by the Piedmont Oncology Association
H B Muss, F Richards, M R Cooper, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 245) with videos related to
Sort By:
Page
of 25
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1985
Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysis
B L Powell, D V Jackson, C W Scarantino, et al.
Cancer
|
April 15, 1981
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trial
H B Muss, V Howard, F Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B
A B Kornblith, D R Hollis, E Zuckerman, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: toxicity and response
C J Bowden, W D Figg, N A Dawson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1986
Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association
F Richards, L D Case, D R White, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1996
Clinical and experimental evidence of inhibition of testosterone production by suramin
R Danesi, R V La Rocca, M R Cooper, et al.
Cancer
|
February 1, 1975
Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma
J H Moon, S Gailani, M R Cooper, et al.
Cancer Treatment Reports
|
July 1, 1985
Phase I study of high-dose cytarabine and cisplatin in patients with advanced malignancy
J N Atkins, H B Muss, R L Capizzi, et al.
The New England Journal of Medicine
|
May 5, 1994
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma
W C Wood, D R Budman, A H Korzun, et al.
Cancer
|
May 1, 1981
Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of Bacillus Calmette-Guerin (MER) in advanced breast cancer: a randomized trial by the Piedmont Oncology Association
H B Muss, F Richards, M R Cooper, et al.
Page
of 25